NPI registry status
Active
2026 NPPES data Dermatopathology Physician NPI 1053474759 M.D.
Verify on CMS → Laura Regan, M.D.
Dermatopathology Physician in Midlothian, Virginia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 577 in Dermatopathology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
828
Medicare Part D claims · 388 beneficiaries · Dermatopathology Physician avg: 695
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Laura Regan, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 828 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 828
- Part D claims, 2024
- 93%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Laura Regan, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1053474759), first enumerated 12/18/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 828 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1053474759 · Dermatopathology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-NEUTRAL · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1053474759
- ENUM-LEGACY 2006
- TAX-NARROW 577
- MIPS-NEUTRAL 75/100
- RX-LIGHT 828
- BOOK-THIN 16 in Virginia
- PHOTO-ENUM Nicholas Bruno · 2006
Laura Regan, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
828 ≥ 72nd percentile 72% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Laura Regan, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Laura Regan, M.D.?
CMS neutral score, not measuredPrimary specialty
Dermatopathology Physician
Medicare Part D claims
828 19% vs specialty avg
MIPS final score
75/100
Specialty distribution in Virginia
How Dermatopathology Physician compares to other specialties among Virginia providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1053474759 |
|---|---|
| Specialty | Dermatopathology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 12/18/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Hospital and facility affiliations
Facilities where Laura Regan, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
James River Dermatology PLLC
Midlothian, VA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Generic-heavy
Laura Regan, M.D. - brand share 7.0%
Dermatopathology Physician average
7% brand-name claims vs 93% generic, on 828 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
828
Total Claims
$294K
Total Drug Cost
388
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,050.167
- Total Day Supply
- 27,707
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $263K
- Generic Drug Cost
- $31K
- Antibiotic Claims
- 118
Patient Demographics
- Average Patient Age
- 75.8 years
- Avg HCC Risk Score
- 0.91
- Gender Split
- 55% female / 45% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Laura Regan, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Fluorouracil
Fluorouracil
105 claims
- Ketoconazole
Ketoconazole
99 claims
- Clobetasol Propion…
Clobetasol Propionate
89 claims
- Doxycycline Hyclate
Doxycycline Hyclate
81 claims
- Triamcinolone Acet…
Triamcinolone Acetonide
73 claims
- Metronidazole 38
Metronidazole
38 claims
- Ciclopirox 28
Ciclopirox
28 claims
- Spironolactone 26
Spironolactone
26 claims
| Drug | Claims |
|---|---|
| Fluorouracil | 105 |
| Ketoconazole | 99 |
| Clobetasol Propionate | 89 |
| Doxycycline Hyclate | 81 |
| Triamcinolone Acetonide | 73 |
| Metronidazole | 38 |
| Ciclopirox | 28 |
| Spironolactone | 26 |
| Valacyclovir Valacyclovir Hcl | 23 |
| Methotrexate Methotrexate Sodium | 22 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatopathology Physician Overview
How Laura Regan, M.D. fits within the Dermatopathology Physician landscape nationally.
577
Dermatopathology Physician Providers in US
48
States with Dermatopathology Physician
695
Avg Claims per Provider
Laura Regan, M.D.'s 828 claims are above the specialty average of 695.
Nationwide Dermatopathology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Regan, both outside Virginia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatopathology Physician Providers in Virginia
Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as Regan.
One of 16 Dermatopathology Physician providers enrolled in Virginia, 5 are shown here.
Dr. Maria Bogaert
M.D.
Winchester, VA
Dr. Lisa Edsall
MD, PHD
North Chesterfield, VA
Dr. Evan Farmer
M.D.
Norfolk, VA
Dr. Kiley Fitzgerald
MD
Roanoke, VA
Dr. Stephen Flax
M.D.
Winchester, VA
Compare Dermatopathology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Laura Regan, M.D.'s specialty? ▼
Laura Regan, M.D. specializes in Dermatopathology Physician and practices in Midlothian, Virginia. Credentials: M.D..
How much does Laura Regan, M.D. prescribe under Medicare Part D? ▼
In 2024, Laura Regan, M.D. wrote 828 Medicare Part D claims totaling $294K in drug costs for 388 beneficiaries.
What is Laura Regan, M.D.'s Medicare quality score? ▼
Laura Regan, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Laura Regan, M.D. located? ▼
Laura Regan, M.D. is located at 1316 ALVERSER PLZ, Midlothian, VA, 23113. Phone: (804) 379-0116.
What is Laura Regan, M.D.'s NPI number? ▼
Laura Regan, M.D.'s National Provider Identifier (NPI) is 1053474759, issued on 12/18/2006.
Does Laura Regan, M.D. prescribe more brand-name or generic drugs? ▼
Laura Regan, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $263K in brand drug costs.
How many Dermatopathology Physician providers are there in the US? ▼
There are 577 Dermatopathology Physician providers across 48 states in the US. The average Dermatopathology Physician provider writes 695 Medicare Part D claims per year.
What drugs does Laura Regan, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Laura Regan, M.D.'s most frequently prescribed drugs include Fluorouracil, Ketoconazole, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Laura Regan, M.D. accept Medicare? ▼
Laura Regan, M.D. appears in CMS Medicare data with 828 Part D claims and 388 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Laura Regan, M.D.'s credentials? ▼
Laura Regan, M.D.'s NPI is 1053474759 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.